Paradym Capital is a Switzerland based private equity investment and asset management company with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. We focus on AI-based investment strategies that leverage advanced algorithms to analyze market trends and optimize investment decisions. At Paradym Capital, our clients benefit from our extensive industry knowledge, experience, and sector-specific relationships. Specializing in the Information Technology and Consumer Discretionary sectors, we provide the targeted expertise necessary to propel your vision forward. We assist our clients in navigating the intricate financial and strategic obstacles encountered at each phase of their business lifecycle. As a prominent, advisory-centric independent investment company, we are well-positioned to act as a reliable advisor in various critical areas, serving our clients‘ needs effectively. Our holdings encompass a select group of no more than 100 companies, primarily focused on the technology and consumer discretionary sectors, each chosen for their high growth potential.

Robert Is Leading The EMEA Activities Of Apotheka From Zurich, Switzerland.

Transaction Strategy & Execution, e.g. M&A Integration, Post-Merger-Integration, Separation, Carve-Outs, IPOs, Spins, JVs, especially in Pharma & Life Sciences, Consumer Products and Industrial Products

M&A Integration & Separation, Financial Management, Corporate Business Planning

Business Transformation, Corporate planning, Sales planning, Business Intelligence

Lecturer for Marketing and Information Systems

Research Assistant - Product Marketing / Procurement Marketing / Business Intelligence / Business Informatics

Sales- and Financial Planning and Forcasting / Controlling for the German CBU (VW Group, Daimler, BMW, Porsche)

Working student